Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Bought by Simplify Asset Management Inc.

Simplify Asset Management Inc. grew its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 51.5% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 23,230 shares of the medical equipment provider’s stock after buying an additional 7,892 shares during the quarter. Intuitive Surgical comprises 0.5% of Simplify Asset Management Inc.’s investment portfolio, making the stock its 20th biggest holding. Simplify Asset Management Inc.’s holdings in Intuitive Surgical were worth $11,412,000 as of its most recent SEC filing.

A number of other institutional investors have also recently modified their holdings of the business. Kingsview Wealth Management LLC raised its holdings in Intuitive Surgical by 1.2% during the first quarter. Kingsview Wealth Management LLC now owns 4,144 shares of the medical equipment provider’s stock worth $1,654,000 after purchasing an additional 51 shares during the last quarter. M&G Plc acquired a new stake in Intuitive Surgical in the 1st quarter valued at about $1,318,000. Nicolet Advisory Services LLC raised its position in Intuitive Surgical by 24.6% during the first quarter. Nicolet Advisory Services LLC now owns 1,059 shares of the medical equipment provider’s stock worth $414,000 after acquiring an additional 209 shares during the last quarter. Spirepoint Private Client LLC acquired a new position in shares of Intuitive Surgical in the first quarter worth $454,000. Finally, Vanguard Group Inc. boosted its stake in shares of Intuitive Surgical by 1.6% during the first quarter. Vanguard Group Inc. now owns 30,868,620 shares of the medical equipment provider’s stock valued at $12,319,358,000 after acquiring an additional 493,126 shares during the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Intuitive Surgical

In other news, SVP Henry L. Charlton sold 40,243 shares of Intuitive Surgical stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $486.84, for a total transaction of $19,591,902.12. Following the transaction, the senior vice president now directly owns 3,001 shares in the company, valued at approximately $1,461,006.84. This trade represents a 93.06 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Jamie Samath sold 269 shares of the firm’s stock in a transaction dated Monday, November 11th. The shares were sold at an average price of $539.89, for a total value of $145,230.41. Following the transaction, the insider now directly owns 8,757 shares of the company’s stock, valued at $4,727,816.73. This represents a 2.98 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 91,178 shares of company stock worth $45,897,071. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Trading Down 0.5 %

ISRG traded down $2.81 on Friday, hitting $534.99. 361,276 shares of the company’s stock were exchanged, compared to its average volume of 1,456,390. The stock has a fifty day moving average of $498.17 and a two-hundred day moving average of $456.22. Intuitive Surgical, Inc. has a twelve month low of $295.02 and a twelve month high of $544.38. The firm has a market cap of $190.55 billion, a PE ratio of 85.80, a P/E/G ratio of 5.28 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.24 by $0.32. The business had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. On average, analysts predict that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on ISRG. BTIG Research set a $535.00 target price on shares of Intuitive Surgical in a report on Friday, October 18th. Robert W. Baird upped their target price on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research note on Thursday, October 17th. Truist Financial raised their target price on shares of Intuitive Surgical from $520.00 to $570.00 and gave the stock a “buy” rating in a research report on Monday, October 14th. Oppenheimer restated a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Finally, Stifel Nicolaus lifted their target price on shares of Intuitive Surgical from $475.00 to $525.00 and gave the company a “buy” rating in a report on Friday, October 18th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have issued a buy rating to the company. According to data from MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average target price of $513.74.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.